Login

Thinkific Labs Inc., a publicly traded company on the TSX , owns the trademark Thinkific. 00:10:00

Share On Facebook Share On Twitter

Greg Smith BCom, LLB, Chief Executive Officer, Co-Founder of Thinkific

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Key Trends Affecting Metals and Mining Private Equity: Insights from Stanham Capital
00:10:00
Securing Your Tomorrow: Medicare and Social Security Decoded | Expert Insights
00:10:00
Behavioral Finance Insights: Strategies for Overcoming Irrational Financial Decisions
00:10:00
Overview of Sabina Gold & Silver's Back River Project
00:10:00
Mastering the Advanced Financial Modeler (AFM) Accreditation: What You Need to Know | Ian Schnoor, Executive Director ,Financial Modeling Institute.
00:10:00
Parsons Corp. CEO Charles Harrington discusses the company's milestone as the first defense firm to go public on "Squawk on the Street."
00:10:00
Murchison Minerals Webinar on Polymetallic Exploration
00:10:00
Axiom Group Introduces NRG Xcite System for Exploration at PDAC
00:10:00
Adapting to Change: Andrew Canobi on Innovative Fixed Income Strategies with Franklin Australian Absolute Return Bond Fund | Andrew Canobi - Director, Australian Fixed Income, Franklin Templeton
00:10:00
Darren Collins of Bald Eagle Gold Corp: Unveiling the Potential of the Hot Springs Property
00:10:00
Solid start of the year for the AMS Osram business, says company CEO Aldo Kamper | Aldo Kamper, CEO, ams Osram AGAMS:SWX
00:10:00
Mirvac Group (ASX:MGR): Susan Lloyd-Hurwitz, Leading the Way as Managing Director & CEO

© 2017 - Neuhu+